40
Participants
Start Date
September 30, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
LAIV H5N2
2 doses provided intranasally
Placebo
2 doses of placebo provided intranasally
Research Institute of Influenza, Saint Petersburg
Collaborators (1)
Microgen
OTHER
Institute of Experimental Medicine, Russia
OTHER
PATH
OTHER